Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

For students, an early social media account may come with a lasting classroom cost

5

Aug 2026

For students, an early social media account may come with a lasting classroom cost

Researchers linked retrospective digital-habit surveys from 5,227 northern Italian students with standardized test records spanning grades 2–10, including 4,545 students in the principal longitudinal analysis. Students who opened social media accounts in grades 6 or 7 had lower later Italian and mathematics scores than matched students who waited until grade 9 or later, although residual confounding cannot be excluded.

The healthiest super-agers may have one thing in common: stable cognition

5

Aug 2026

The healthiest super-agers may have one thing in common: stable cognition

A 10-year study of 1,003 older adults linked cognitive super-aging to fewer emergency visits, unplanned hospital admissions, delirium episodes, dementia diagnoses, and residential aged care placements. Maintaining cognitive performance over time showed the strongest overall association with favorable health outcomes and was linked to a 46% lower mortality risk.

Mouse study shows how liraglutide briefly rewires gut bacterial communities

4

Aug 2026

Mouse study shows how liraglutide briefly rewires gut bacterial communities

Researchers treated male high-fat-fed mice with liraglutide for 14 days, then tracked fecal bacterial communities after a 7-day washout using 16S rRNA sequencing. Liraglutide shifted the microbiome toward Lactobacillus- and Leptogranulimonas-related taxa while reducing several fermentative taxa, but most changes moved back toward baseline after treatment stopped.

Occupational pesticide exposure may significantly increase ALS risk

4

Aug 2026

Occupational pesticide exposure may significantly increase ALS risk

Workplace exposure to pesticides (herbicides and insecticides) is linked to a 60-70% heightened risk of the most common form of motor neuron disease-amyotrophic lateral sclerosis, or ALS for short, finds a synthesis of the available evidence, published online in Occupational & Environmental Medicine.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.